Neuropathogenicity and susceptibility to immune response are interdependent properties of Lactate Dehydrogenase-elevating Virus (LDV) and correlate with the number of N-linked polylactosaminoglycan chains on the ectodomain of the primary envelope glycoprotein

Advances in Experimental Medicine and Biology

Volumn 440, Issue , 1998, Pages 583-592

  Chen, Zongyu ^a   Li, Kehan ^a   Rowland, Raymond R R ^b   Plagemann, Peter G W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; POLYLACTOSAMINOGLYCAN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; IMMUNE RESPONSE; LACTIC DEHYDROGENASE TOGAVIRUS; MOUSE; NEUROPATHOLOGY; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; AMINO SUGARS; ANIMALS; BASE SEQUENCE; BINDING SITES; DNA, VIRAL; LACTATE DEHYDROGENASE-ELEVATING VIRUS; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; VIRAL ENVELOPE PROTEINS;

ANIMALIA; LACTATE DEHYDROGENASE-ELEVATING VIRUS; TOGAVIRIDAE;

EID: 0031721785     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5331-1_76     Document Type: Article

References (23)

1. Anderson, G.W., Even, C., Rowland, R.R.R., Palmer, G.A., Harty, J.T., and Plagemann, P.G.W., 1995a, C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age, J. Neurovirol. 1: 244-252.
2. Anderson, G.W., Palmer, G. A., Rowland, R.R.R., Even, C., and Plagemann, P.G.W., 1995b, Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in utero infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus, J. Virol. 69: 308-319.
3. Cafruny, W.A., Chan, S.P.K., Harty, J.T., Yousefi, S., Kowalchyk, K., McDonald, D., Foreman, B., Budweg, G., and Plagemann, P.G.W., 1986, Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus, Virus Res. 5: 357-375.
4. Cavanagh, D., Brian, D.A., Brinton, M., Enjuanes, L., Horzinek, M.C., Lai, M.M.C., Laude, H., Plagemann, P.G.W., Siddell, S., Spaan, W.J.M., and Talbot, P.J., 1997, Nidovirales: a new order comprising Coronaviridae and Art-Chen, Z., Kuo, L., Rowland, R.R.R., Even, C., Faaberg, K.S. and Plagemann, P.G.W., 1993, Sequence of 3′-end of genome and of 5′-end of ORF 1a of lactate dehydrogenase-elevating and common junction motifs between 5′-leader and bodies of subgenomic mRNAs, J. Gen. Virol. 74: 643-660.
5. Chen, Z., and Plagemann, P.G.W., 1997, Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cells, J. Virol. Meth. In press.
6. Chen, Z., Rowland, R.R.R., Anderson, G.W., and Plagemann, P.G.W., 1997a, Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection, J. Virol. 71: 2913-2920.
7. Chen, Z., Li, K., Rowland, R.R.R., Anderson, G.W., Schuler, T.W., and Plagemann, P.G.W., 1997b, Neuropathogenicity and low viremia during persistent infection are related properties of lactate dehydrogenase-elevating virus and are associated with lacking two of three N-glycosylation sites on the ectodomain of primary envelope glycoprotein, submitted to Virology.
8. Coutelier, J.P. and van Snick, J., 1988, Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies, J. Gen. Virol. 69: 2097-2100.
9. Coutelier, J.P., van Roost, F., Lambotte, P., and van Snick, J., 1986, The murine antibody response to lactate dehydrogenase-elevating virus, J. Gen. Virol. 61: 1099-1108.
10. Domingo, E. and Holland, J.J., 1994, Mutations and rapid evolution of RNA viruses, in The Evolutionary Biology of Viruses, pp 161-184. Edited by S.S. Morse. New York: Raven Press.
11. Faaberg, K.S., and Plagemann, P.G.W., 1995, The envelope proteins of lactate dehydrogenase-elevating virus and their membrane topography, Virology 212: 512-525.
12. Faaberg, K.S., Even, C., Palmer, G.A., and Plagemann, P.G.W., 1995a, Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity, J. Virol. 69: 613-617.
13. Faaberg, K.S., Palmer, G.A., Even, C., Anderson, G.W., and Plagemann, P.G.W., 1995b, Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase-elevating virus that differ in Neuropathogenicity, Virus Res. 39: 331-340.
14. Harty, J.T., and Plagemann, P.G.W., 1988, Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection, J. Virol. 62: 3210-3216.
15. Holland, J.J., de la Torre, J.C. and Steinhauer, D.A., 1992, RNA virus populations as quasispecies, Curr. Top. Microbiol. Immunol. 176: 1-18.
16. Li, K, Chen, Z and Plagemann, P.G.W., 1997, Differences in sensitivity to in vitro neutralization between different lactate dehydrogenase-elevating virus quasispecies correlates with differences in number of polylactosaminoglycan chains associated with neutralizing epitope on the ectodomain of primary envelope glycoprotein, submitted to Virology.
17. Meulenberg, J.J.M., Hulst, M.M., de Meijer, E.J., Moonen, P.J.L.M., den Besten, A., de Kluyver, E.P., Wensvoort, G., and Moormann, R.J.M., 1993, Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV, Virology 192: 62-72.
18. Murphy, W.H., Nawrocki, J.F., and Pease, L.R., 1983, Age-dependent paralytic viral infection in C58 mice: Possible implication in human neurologic disease, Prog. Brain Res. 59: 291-303.
19. Murphy, W.H., Mazur, J.J. and Fulton, S.A., 1987, Animal model for motor neuron disease, in Clinical Neuroimmunology, pp 135-155. Edited by W.M.H. Behan, P.O. Behan & J.A. Aarli. Oxford, England: Blackwell Scientific Publications.
20. Murtaugh, M.P., Elam, I.R., and Kakach, L.T., 1995, Comparison of the structural protein coding sequences of the VR2332 and Lelystad virus strains of the PRRS virus, Arch. Virol. 140: 1451-1460.
21. Plagemann, P.G.W., 1996, Lactate dehydrogenase-elevating virus and related viruses, in Virology, 3rd Edition, pp 1105-1120. Edited by B.N. Fields, D.M. Knipe, and P.M. Howley. New York: Raven Press.
22. Plagemann, P.G.W., Gregory, K.F., Swim, H.E. and Chan, K.K.W., 1963, Plasma lactic dehydrogenase elevating agent of mice: Distribution in tissues and effect on lactic dehydrogenase isozyme patterns, Can. J. Microbiol. 9: 75-86.
23. Plagemann, P.G.W., Rowland, R.R.R., Even, C., and Faaberg, K.S., 1995, Lactate dehydrogenase-elevating virus - an ideal persistent virus? Semin. Immunopathol. 17: 167-186.